| scholarly article | Q13442814 |
| P50 | author | Maria Zingariello | Q57067419 |
| P2093 | author name string | Anna Rita Migliaccio | |
| Eva Zetterberg | |||
| Fabrizio Martelli | |||
| Emanuela D'Amore | |||
| Laura Sancillo | |||
| Rosa Alba Rana | |||
| Maria Verrucci | |||
| P2860 | cites work | Proteomic and functional characterisation of platelet microparticle size classes | Q50312260 |
| Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. | Q51732019 | ||
| Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. | Q54536225 | ||
| Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice | Q58211924 | ||
| Thrombosis in primary myelofibrosis: incidence and risk factors | Q61050096 | ||
| Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia | Q61050102 | ||
| Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes | Q61819548 | ||
| Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes | Q73012008 | ||
| Leukocyte-leukocyte interactions mediated by platelet microparticles under flow | Q73426888 | ||
| Myelofibrosis with myeloid metaplasia | Q73712758 | ||
| Angiogenesis in P- and E-selectin-deficient mice | Q77466532 | ||
| Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status | Q79365558 | ||
| Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution | Q81528363 | ||
| Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera | Q28174281 | ||
| Indices of platelet activation and the stability of coronary artery disease | Q28221194 | ||
| Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin | Q31144359 | ||
| Consequences of GATA-1 deficiency in megakaryocytes and platelets | Q33328560 | ||
| Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). | Q33337239 | ||
| Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis | Q33358292 | ||
| Human phenotypes associated with GATA-1 mutations | Q33381670 | ||
| X-linked thrombocytopenia with thalassemia in two families in Sweden. Consider hereditary causes of thrombocytopenia and bone marrow fibrosis | Q33403427 | ||
| Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. | Q34549341 | ||
| Microparticles in hemostasis and thrombosis. | Q35131040 | ||
| Pro-coagulant state resulting from high levels of soluble P-selectin in blood | Q35578042 | ||
| The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor | Q35628909 | ||
| Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. | Q35651662 | ||
| A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. | Q36240033 | ||
| An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice | Q36299027 | ||
| GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant | Q36370557 | ||
| New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients. | Q36524052 | ||
| Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. | Q36831712 | ||
| Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation | Q36979002 | ||
| Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation | Q37348257 | ||
| Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease | Q37353939 | ||
| P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. | Q37612342 | ||
| Platelet–Leukocyte Interactions in Cardiovascular Disease and Beyond | Q37808902 | ||
| Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. | Q37934479 | ||
| Platelet-leukocyte interactions in thrombosis | Q37954861 | ||
| Front-line therapy in polycythemia vera and essential thrombocythemia | Q38025532 | ||
| Thrombotic disease in the myeloproliferative neoplasms. | Q38066925 | ||
| Bleeding and thrombosis in the myeloproliferative disorders | Q40179485 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). | Q44083612 | ||
| Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes | Q45261378 | ||
| Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. | Q46186672 | ||
| Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan | Q46674485 | ||
| Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis | Q46979105 | ||
| Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera | Q47416647 | ||
| P433 | issue | 7 | |
| P921 | main subject | thrombosis | Q261327 |
| myelofibrosis | Q1752571 | ||
| P304 | page(s) | 539-547 | |
| P577 | publication date | 2013-10-31 | |
| P1433 | published in | Platelets | Q1573582 |
| P1476 | title | Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis | |
| P478 | volume | 25 |
| Q50201003 | GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy |
| Q58701086 | Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver |
| Q60922706 | New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches |
| Q33438367 | The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer |
| Q90592727 | Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia |
| Q60922703 | Vascular endothelial cell expression of JAK2 is sufficient to promote a pro-thrombotic state due to increased P-selectin expression |
Search more.